A convenient solid-phase method for the synthesis of novel oligonucleotide-folate conjugates
Eugenia V Kazanova1, Eugeny M Zubin, Anna V Kachalova
1Department of Chemistry and A. N. Belozersky Institute of Physico-Chemical Biology, M. V. Lomonossov Moscow State University, Moscow, Russia.
Nucleosides, Nucleotides & Nucleic Acids
|December 11, 2007
Summary
Researchers developed a new polymer support for attaching folic acid to oligonucleotides. This method enables regioselective synthesis of oligonucleotide-folate conjugates for enhanced cell delivery applications.
Area of Science:
- Bioconjugation Chemistry
- Oligonucleotide Synthesis
- Drug Delivery Systems
Background:
- Folic acid is crucial for cell targeting due to folate receptor expression on various cancer cells.
- Oligonucleotide-based therapeutics require efficient delivery systems for improved efficacy.
- Developing regioselective conjugation methods is essential for creating functional oligonucleotide-folate conjugates.
Purpose of the Study:
- To prepare and characterize novel polymer supports for folic acid incorporation into oligonucleotides.
- To establish a regioselective method for attaching nucleic acid sequences to L-glutamic acid via its alpha- or gamma-carboxyl group.
- To evaluate the utility of these supports in synthesizing oligonucleotide-folate conjugates for cell delivery studies.
Main Methods:
- Preparation of two distinct polymer support batches.
- Regioselective solid-phase synthesis utilizing the 3'-end of oligonucleotides.
- Attachment to either the alpha- or gamma-carboxyl group of L-glutamic acid.
- Synthesis of oligonucleotide-folate conjugates.
Main Results:
- Successful preparation of two polymer support batches.
- Demonstration of regioselective attachment of oligonucleotides to specific carboxyl groups of L-glutamic acid.
- Synthesis of functional oligonucleotide-folate conjugates confirmed.
Conclusions:
- The developed polymer supports facilitate the regioselective incorporation of folic acid into oligonucleotides.
- This method provides a robust platform for creating oligonucleotide-folate conjugates for cell delivery applications.
- The synthesized conjugates show potential for targeted delivery studies.


